Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry
- PMID: 17117458
- DOI: 10.1002/rcm.2787
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry
Abstract
The 40 and 42 amino-acid residue forms of amyloid beta (Abeta(1-40) and Abeta(1-42)) in cerebrospinal fluid (CSF) have been proposed as potential biomarkers of Alzheimer's disease (AD). Quantitative analyses of Abeta peptides in CSF have relied almost exclusively on the use of immunoassay-based assays such as the enzyme-linked immunosorbent assay (ELISA) procedure. However, due to the ability of the Abeta peptides to readily self-aggregate or bind to other proteins and glassware, such analyses are extremely challenging. Analyses are further complicated by the potential of the peptides to undergo post-translational modifications and the possibilities for cross-reaction in the ELISA assays with endogenous components of the CSF. An approach based on liquid chromatography/tandem mass spectrometry (LC/MS/MS) has now been developed which overcomes these methodological issues. The key steps in implementing this new approach involved immunoaffinity purification coupled with the use of [15N]-labeled Abeta peptides as internal standards, a basic LC mobile phase, negative ion electrospray ionization, and a basic solvent for dissolving the peptides and washing the injection needle to prevent carryover of analytes during multiple injections on the LC/MS system. The validated method had limits of quantitation of 44 fmol/mL (200 pg/mL) for Abeta(1-42) and 92 fmol/mL (400 pg/mL) for Abeta(1-40). An excellent correlation was found between the LC/MS/MS assay and an ELISA assay for Abeta(1-42) in human CSF (r2 = 0.915), although less correlation was observed for Abeta(1-40) (r2 = 0.644). Mean CSF Abeta(1-42) concentrations for samples collected 2 weeks apart from a limited number of AD patients provided additional confidence in the reproducibility of the LC/MS/MS assay. Concentrations for duplicate samples from AD patients were slightly higher than most previously reported values (mean 1.06 +/- 0.25 ng/mL; n = 7). Abeta(1-40) concentrations in duplicate samples obtained from AD patients were also reproducible but were found to be slightly lower than most previously reported values (mean 6.36 +/- 3.07 ng/mL; n = 7). Consistent with literature reports, mean Abeta(1-42) concentrations were found to be lower in AD patients compared with the normal subjects (mean 1.49 +/- 0.59 ng/mL; n = 7), whereas there was no difference in Abeta(1-40) concentrations between AD patients and normal subjects (mean 5.88 +/- 3.03 ng/mL; n = 7). The accuracy and precision of the LC/MS assay mean that it will be a useful complement to existing ELISA assays for monitoring therapeutic interventions designed to modulate CSF Abeta(1-42) concentrations in individual AD patients. Moreover, the introduction of stable isotope labeled internal standards offers the potential to achieve a more rigorous account of the influence of methodological effects related to sample collection and processing.
Copyright 2006 John Wiley & Sons, Ltd.
Similar articles
-
Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry.Brief Funct Genomic Proteomic. 2007 Jun;6(2):149-58. doi: 10.1093/bfgp/elm010. Epub 2007 Jun 20. Brief Funct Genomic Proteomic. 2007. PMID: 17584762
-
Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.Biol Psychiatry. 2004 Mar 1;55(5):524-30. doi: 10.1016/j.biopsych.2003.10.014. Biol Psychiatry. 2004. PMID: 15023581 Clinical Trial.
-
No correlation between time-linked plasma and CSF Abeta levels.Neurochem Int. 2009 Dec;55(8):820-5. doi: 10.1016/j.neuint.2009.08.006. Epub 2009 Aug 18. Neurochem Int. 2009. PMID: 19695299
-
Stable-isotope dilution LC-ESI-MS/MS techniques for the quantification of total homocysteine in human plasma.J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 15;877(28):3292-9. doi: 10.1016/j.jchromb.2009.07.024. Epub 2009 Jul 21. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19651543 Review.
-
Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.Scand J Clin Lab Invest. 2009;69(1):8-12. doi: 10.1080/00365510701864610. Scand J Clin Lab Invest. 2009. PMID: 18609117 Review.
Cited by
-
Identifying and validating biomarkers for Alzheimer's disease.Trends Biotechnol. 2011 Jan;29(1):26-32. doi: 10.1016/j.tibtech.2010.09.007. Epub 2010 Oct 23. Trends Biotechnol. 2011. PMID: 20971518 Free PMC article. Review.
-
Targeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography-tandem mass spectrometry.J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Sep 15;877(26):2736-45. doi: 10.1016/j.jchromb.2009.03.011. Epub 2009 Mar 17. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19345647 Free PMC article. Review.
-
Analysis of the zebrafish proteome during embryonic development.Mol Cell Proteomics. 2008 May;7(5):981-94. doi: 10.1074/mcp.M700382-MCP200. Epub 2008 Jan 22. Mol Cell Proteomics. 2008. PMID: 18212345 Free PMC article.
-
Serum apolipoprotein A-1 quantification by LC-MS with a SILAC internal standard reveals reduced levels in smokers.Bioanalysis. 2015;7(22):2895-911. doi: 10.4155/bio.15.195. Epub 2015 Sep 22. Bioanalysis. 2015. PMID: 26394123 Free PMC article.
-
An LC-MS/MS-based platform for the quantification of multiple amyloid beta peptides in surrogate cerebrospinal fluid.J Mass Spectrom Adv Clin Lab. 2024 Jan 22;31:40-48. doi: 10.1016/j.jmsacl.2024.01.002. eCollection 2024 Jan. J Mass Spectrom Adv Clin Lab. 2024. PMID: 38375485 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical